companydata.dkcompanydata.dk

Octarine Bio ApS: Financial statements 2020

CVR: 39857316

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

Octarine Bio ApS (CVR 39857316) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 916,667 and a net result of DKK -2,372,514. Equity in the 2020 report amounted to DKK -900,219. The company had 3 employees in the financial year.

Gross Profit
DKK 916,667
Profit/Loss
DKK -2,372,514
Equity
DKK -900,219
Total Assets
DKK 9,331,520
Employees
3

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Octarine Bio ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Octarine Bio IVS changes name to Octarine Bio ApSOct 14, 2020

On October 14, 2020, the company changed its name from Octarine Bio IVS to Octarine Bio ApS.

Alexandre Ouimet-Storrs joins the board of Octarine Bio ApSSep 10, 2020

As of September 10, 2020, Alexandre Ouimet-Storrs has joined the board of directors of Octarine Bio ApS.

Octarine Bio ApS publishes interim reportAug 21, 2020

Octarine Bio ApS has published its interim report for the period September 12, 2018 – December 31, 2019.

Stephan Christgau joins the board of Octarine Bio ApSJun 30, 2020

As of June 30, 2020, Stephan Christgau has joined the board of directors of Octarine Bio ApS.

Helga Claudia Blomgren-Hansen joins the board of Octarine Bio ApSJun 30, 2020

As of June 30, 2020, Helga Claudia Blomgren-Hansen has joined the board of directors of Octarine Bio ApS.

Christian Brix Tillegreen joins the board of Octarine Bio ApSJun 30, 2020

As of June 30, 2020, Christian Brix Tillegreen has joined the board of directors of Octarine Bio ApS.

Octarine Bio ApS appoints new auditorFeb 24, 2020

As of February 24, 2020, Ri Magnoliavej 12 ApS has been appointed auditor of Octarine Bio ApS.

About Octarine Bio ApS

Octarine Bio ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Octarine Bio IVS. The management consists of Nethaji Janeshawari Gallage and Nicholas Stuart William Milne. The board consists of Stephan Christgau (chair), Akshat Kshetrapal, Alexandre Ouimet-Storrs and Marianne Tochtermann. The company's owners include Nicholas Stuart William Milne, Biosphere ApS and UV Fund I K/S. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 1,715,333 and a net result of DKK -11,501,321 compared with DKK -22,298,751 the year before. Equity in the 2025 report amounted to DKK 31,907,827.

Source: annual report 2025, Danish Business Authority

Other financial years